Calypso Biotech Competitors and Similar CompaniesClear all
Calypso Biotech's competitors and similar companies include ReViral, Cullgen, Evox Therapeutics and Keros Therapeutics.
 Cullgen Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders. |  Evox Therapeutics Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies. |  Keros Therapeutics Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta. | |||
Founding Date | Founding Date 2013 | Founding Date 2011 | Founding Date 2018 | Founding Date 2016 | Founding Date 2015 |
Type | Type Private | Type Private | Type Private | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations Plan-les-Ouates, CH HQ Amsterdam, NL | Locations Stevenage, GB HQ Durham, US | Locations San Diego, US HQ Shanghai, CN Tokyo, JP | Locations Oxford, GB HQ | Locations Lexington, US HQ South Wharf, AU |
Employees | Employees 12 | Employees 5 | Employees 4 | Employees 452% decrease | Employees 7854% decrease |
Funding | |||||
Latest funding round | Latest funding round $ 22.8m (over 7 years ago) | Latest funding round $ 44m (over 5 years ago) | Latest funding round $ 16m (about 7 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 26.1m | Total funding raised $ 121m | Total funding raised $ 31m | Total funding raised $ 158.6m | Total funding raised $ 90m |
For sources of this data, please see the company profile
View Company Profiles
ReViral
HQ
Stevenage, GB
Employees
5
ReViral is a biotechnology company developing drugs to treat RSV infections.
View companyCullgen
HQ
San Diego, US
Employees
4
Cullgen is a biotech drug discovery company dedicated to the development of targeted protein degraders.
View companyEvox Therapeutics
HQ
Oxford, GB
Evox Therapeutics is a biotechnology company developing exosome-based gene editing therapies.
View companyKeros Therapeutics
HQ
Lexington, US
Employees
78
Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta.
View company